Max Chat
Company Analysis CEL-SCI Corporation
1. Summary
Advantages
- The stock's return over the last year (98.25%) is higher than the sector average (-41.8%).
- Current debt level 43.06% is below 100% and has decreased over 5 years from 48.9%.
Disadvantages
- Price (2.26 $) is higher than fair price (1.91 $)
- Dividends (0%) are below the sector average (1.28%).
- The company's current efficiency (ROE=-206.43%) is lower than the sector average (ROE=-83.32%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| CEL-SCI Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -5% | 0% | 0% |
| 90 days | 1047.2% | -39.8% | 17.7% |
| 1 year | 98.2% | -41.8% | 11.4% |
CVM vs Sector: CEL-SCI Corporation has outperformed the "Healthcare" sector by 140.05% over the past year.
CVM vs Market: CEL-SCI Corporation has outperformed the market by 86.8% over the past year.
Highly volatile price: CVM is significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical deviations of more than +/- 15% per week.
Long period: CVM with weekly volatility of 1.89% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2.26 $) is higher than the fair price (1.91 $).
Price is higher than fair: The current price (2.26 $) is 15.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (61.84).
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.45) is lower than that of the sector as a whole (10.86).
P/BV vs Market: The company's P/BV (4.45) is lower than that of the market as a whole (20.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (15.26) is higher than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (15.26) is lower than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.89) is lower than that of the sector as a whole (16.29).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.89) is lower than that of the market as a whole (18.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -2.2% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-2.2%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (-206.43%) is lower than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (-206.43%) is lower than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (-93.6%) is lower than that of the sector as a whole (6.38%).
ROA vs Market: The company's ROA (-93.6%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.07%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.15%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.28%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
